These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38148440)

  • 21. Klotho prevents epithelial-mesenchymal transition through Egr-1 downregulation in diabetic kidney disease.
    Li Y; Xue M; Hu F; Jia Y; Zheng Z; Yang Y; Liu X; Yang Y; Wang Y
    BMJ Open Diabetes Res Care; 2021 Jun; 9(1):. PubMed ID: 34099438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective role of Trpc6 knockout in the progression of diabetic kidney disease.
    Spires D; Ilatovskaya DV; Levchenko V; North PE; Geurts AM; Palygin O; Staruschenko A
    Am J Physiol Renal Physiol; 2018 Oct; 315(4):F1091-F1097. PubMed ID: 29923767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long noncoding RNA NEAT1 is involved in the protective effect of Klotho on renal tubular epithelial cells in diabetic kidney disease through the ERK1/2 signaling pathway.
    Yang YL; Xue M; Jia YJ; Hu F; Zheng ZJ; Wang L; Si ZK; Xue YM
    Exp Mol Med; 2020 Feb; 52(2):266-280. PubMed ID: 32054986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zuogui-Jiangtang-Yishen decoction prevents diabetic kidney disease: Intervene pyroptosis induced by trimethylamine n-oxide through the mROS-NLRP3 axis.
    Yi ZY; Peng YJ; Hui BP; Liu Z; Lin QX; Zhao D; Wang Y; Liu X; Xie J; Zhang SH; Huang JH; Yu R
    Phytomedicine; 2023 Jun; 114():154775. PubMed ID: 36990008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mouse Models of Diabetes, Obesity and Related Kidney Disease.
    Glastras SJ; Chen H; Teh R; McGrath RT; Chen J; Pollock CA; Wong MG; Saad S
    PLoS One; 2016; 11(8):e0162131. PubMed ID: 27579698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PFKP Activation Ameliorates Foot Process Fusion in Podocytes in Diabetic Kidney Disease.
    Zhang Z; Liang W; Luo Q; Hu H; Yang K; Hu J; Chen Z; Zhu J; Feng J; Zhu Z; Chi Q; Ding G
    Front Endocrinol (Lausanne); 2021; 12():797025. PubMed ID: 35095764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poricoic acid A induces mitophagy to ameliorate podocyte injury in diabetic kidney disease via downregulating FUNDC1.
    Wu Y; Deng H; Sun J; Tang J; Li X; Xu Y
    J Biochem Mol Toxicol; 2023 Dec; 37(12):e23503. PubMed ID: 37706594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrating metabolomics and network pharmacology to investigate Panax japonicus prevents kidney injury in HFD/STZ-induced diabetic mice.
    Wang T; Huang X; Zhai K; Yu J; Li J; Duan H; Liu J; Lu Z; Guo J; Li F
    J Ethnopharmacol; 2023 Mar; 303():115893. PubMed ID: 36368565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CCDC92 deficiency ameliorates podocyte lipotoxicity in diabetic kidney disease.
    Zuo F; Wang Y; Xu X; Ding R; Tang W; Sun Y; Wang X; Zhang Y; Wu J; Xie Y; Liu M; Wang Z; Yi F
    Metabolism; 2024 Jan; 150():155724. PubMed ID: 37952690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ATF5 regulates tubulointerstitial injury in diabetic kidney disease via mitochondrial unfolded protein response.
    Liu Y; Zhang L; Zhang S; Liu J; Li X; Yang K; Yang D; Liu Y; Sun L; Liu F; Xiao L
    Mol Med; 2023 Apr; 29(1):57. PubMed ID: 37095454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alpha lipoamide inhibits diabetic kidney fibrosis via improving mitochondrial function and regulating RXRα expression and activation.
    Zhang HF; Liu HM; Xiang JY; Zhou XC; Wang D; Chen RY; Tan WL; Liang LQ; Liu LL; Shi MJ; Zhang F; Xiao Y; Zhou YX; Zhang T; Tang L; Guo B; Wang YY
    Acta Pharmacol Sin; 2023 May; 44(5):1051-1065. PubMed ID: 36347997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diabetic kidney diseases revisited: A new perspective for a new era.
    Fu H; Liu S; Bastacky SI; Wang X; Tian XJ; Zhou D
    Mol Metab; 2019 Dec; 30():250-263. PubMed ID: 31767176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LC-MS-based metabolomics analysis to identify meprin-β-associated changes in kidney tissue from mice with STZ-induced type 1 diabetes and diabetic kidney injury.
    Gooding J; Cao L; Ahmed F; Mwiza JM; Fernander M; Whitaker C; Acuff Z; McRitchie S; Sumner S; Ongeri EM
    Am J Physiol Renal Physiol; 2019 Oct; 317(4):F1034-F1046. PubMed ID: 31411076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Baicalin ameliorates renal fibrosis by upregulating CPT1α-mediated fatty acid oxidation in diabetic kidney disease.
    Hu H; Li W; Hao Y; Peng Z; Zou Z; Liang W
    Phytomedicine; 2024 Jan; 122():155162. PubMed ID: 37922789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sacubitril/Valsartan contributes to improving the diabetic kidney disease and regulating the gut microbiota in mice.
    Wang P; Guo R; Bai X; Cui W; Zhang Y; Li H; Shang J; Zhao Z
    Front Endocrinol (Lausanne); 2022; 13():1034818. PubMed ID: 36589853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe hypertriglyceridemia and hypercholesterolemia accelerating renal injury: a novel model of type 1 diabetic hamsters induced by short-term high-fat / high-cholesterol diet and low-dose streptozotocin.
    He L; Hao L; Fu X; Huang M; Li R
    BMC Nephrol; 2015 Apr; 16():51. PubMed ID: 25884847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liraglutide ameliorates early renal injury by the activation of renal FoxO1 in a type 2 diabetic kidney disease rat model.
    Chen P; Shi X; Xu X; Lin Y; Shao Z; Wu R; Huang L
    Diabetes Res Clin Pract; 2018 Mar; 137():173-182. PubMed ID: 29355652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human carnosinase 1 overexpression aggravates diabetes and renal impairment in BTBR
    Qiu J; Albrecht T; Zhang S; Hauske SJ; Rodriguez-Niño A; Zhang X; Nosan D; Pastene DO; Sticht C; Delatorre C; van Goor H; Porubsky S; Krämer BK; Yard BA
    J Mol Med (Berl); 2020 Sep; 98(9):1333-1346. PubMed ID: 32803273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic efficacy of dapagliflozin on diabetic kidney disease in rats.
    Yang H; Mei Z; Chen W; Pan Y; Liu L; Zhao R; Ni W; Wang Y; Fei C
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109272. PubMed ID: 36252493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Probiotics improve renal function, glucose, lipids, inflammation and oxidative stress in diabetic kidney disease: a systematic review and meta-analysis.
    Dai Y; Quan J; Xiong L; Luo Y; Yi B
    Ren Fail; 2022 Dec; 44(1):862-880. PubMed ID: 35611435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.